Skip to main content
OpenTrials

Clinical trial condition

High-grade B-cell Lymphoma

Explore clinical trials studying High-grade B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

37 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

High-grade B-cell Lymphoma trial results

Recruiting

Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

NCT06588205

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, +11 more
Locations
  • A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia Alessandria, Italy
  • A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
  • I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
  • ASST Spedali Civili - S.C. Ematologia Brescia, Italy
View all 20 locations
View Trial Details
Recruiting

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

NCT06736613

Conditions
DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, +21 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Not Yet Recruiting

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT07225439

Conditions
B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
Locations
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
View Trial Details
Completed

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

NCT05653271

Conditions
B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
Locations
  • AdventHealth Orlando Orlando, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 13 locations
View Trial Details

Related conditions